Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
- PMID: 7542548
- DOI: 10.1016/1074-7613(95)90157-4
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
Abstract
CD19-deficient mice were generated to examine the role of CD19 in B cell growth regulation in vivo. Deletion of CD19 had no deleterious effects on the generation of B cells in the bone marrow, but there was a significant reduction in the number of B cells in peripheral lymphoid tissues. B cells from CD19-deficient mice exhibited markedly decreased proliferative responses to mitogens, and serum immunoglobulin levels were also significantly decreased. In contrast, mice that overexpressed CD19 had significant defects in early B cell development in the bone marrow, augmented mitogenic responses, and increased serum immunoglobulin levels. These experiments indicate that CD19 functions to define signaling thresholds for cell surface receptors that regulate B lymphocyte selection, activation, and differentiation.
Similar articles
-
Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.Mol Cell Biol. 1994 Jun;14(6):3884-94. doi: 10.1128/mcb.14.6.3884-3894.1994. Mol Cell Biol. 1994. PMID: 7515149 Free PMC article.
-
Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.Nature. 1995 Jul 27;376(6538):352-5. doi: 10.1038/376352a0. Nature. 1995. PMID: 7543183
-
CD19 signaling pathways play a major role for murine AIDS induction and progression.J Immunol. 2002 Nov 15;169(10):5607-14. doi: 10.4049/jimmunol.169.10.5607. J Immunol. 2002. PMID: 12421939
-
The CD19/CD21 signal transduction complex of B lymphocytes.Immunol Today. 1994 Sep;15(9):437-42. doi: 10.1016/0167-5699(94)90274-7. Immunol Today. 1994. PMID: 7524521 Review.
-
Fidelity and infidelity in commitment to B-lymphocyte lineage development.Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.
Cited by
-
B-cell targeted therapeutics in clinical development.Arthritis Res Ther. 2013;15 Suppl 1(Suppl 1):S4. doi: 10.1186/ar3906. Epub 2013 Apr 4. Arthritis Res Ther. 2013. PMID: 23566679 Free PMC article. Review.
-
B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2594-615. doi: 10.2741/4073. Front Biosci (Landmark Ed). 2012. PMID: 22652800 Free PMC article. Review.
-
AKT Isoforms in the Immune Response in Cancer.Curr Top Microbiol Immunol. 2022;436:349-366. doi: 10.1007/978-3-031-06566-8_15. Curr Top Microbiol Immunol. 2022. PMID: 36243852
-
B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.Immunology. 2007 Sep;122(1):73-9. doi: 10.1111/j.1365-2567.2007.02614.x. Epub 2007 Apr 30. Immunology. 2007. PMID: 17472721 Free PMC article.
-
"Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology.Front Immunol. 2018 May 9;9:966. doi: 10.3389/fimmu.2018.00966. eCollection 2018. Front Immunol. 2018. PMID: 29867948 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous